Continue to Site

Tela Bio raises more than $2 million

December 11, 2018 By Chris Newmarker

Regenerative surgical implants company Tela Bio has brought in more than $2 million in investments, according to a recent U.S. Securities and Exchange Commission filing.

The Malvern, Pa.–based company had sought to raise a total $3 million, according to the SEC Form D filed Dec. 4.

Privately-held Tela Bio announced in March that it landed a $1 million investment from ProMedica, a nonprofit healthcare group serving northwest Ohio and southern Michigan.

The company said a month later that Checkmate Capital, a strategic investment group based in Los Angeles and Beijing, had agreed to an initial Series B investment.

Tela Bio’s OviTex reinforced bioscaffolds products are meant for hernia repair and abdominal wall reconstruction. They compbine polymer and biologic materials in what the company describes as a uniquely embroidered construction.

About Chris Newmarker

Chris Newmarker is the executive editor of WTWH Media life science's news websites and publications including MassDevice, Medical Design & Outsourcing and more. A professional journalist of 18 years, he is a veteran of UBM (now Informa) and The Associated Press whose career has taken him from Ohio to Virginia, New Jersey and, most recently, Minnesota. He’s covered a wide variety of subjects, but his focus over the past decade has been business and technology. He holds bachelor’s degrees in journalism and political science from Ohio State University. Connect with him on LinkedIn or email at cnewmarker@wtwhmedia.com.